Marshall Wace, LLP Wave Life Sciences Ltd. Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

A detailed history of Marshall Wace, LLP transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Marshall Wace, LLP holds 128,550 shares of WVE stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128,550
Previous 62,102 107.0%
Holding current value
$1.74 Million
Previous $309,000 241.1%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$5.12 - $9.01 $340,213 - $598,696
66,448 Added 107.0%
128,550 $1.05 Million
Q2 2024

Aug 14, 2024
SELL
$4.38 - $6.48 $1.1 Million - $1.63 Million
-251,303 Reduced 80.18%
62,102 $309,000
Q1 2024

May 15, 2024
SELL
$3.54 - $6.84 $661,286 - $1.28 Million
-186,804 Reduced 37.35%
313,405 $1.93 Million
Q4 2023

Feb 14, 2024
BUY
$4.16 - $6.87 $1.33 Million - $2.19 Million
318,571 Added 175.39%
500,209 $2.53 Million
Q3 2023

Nov 14, 2023
SELL
$3.56 - $5.75 $151,364 - $244,478
-42,518 Reduced 18.97%
181,638 $1.04 Million
Q2 2023

Aug 14, 2023
SELL
$3.51 - $4.69 $510,122 - $681,616
-145,334 Reduced 39.33%
224,156 $815,000
Q1 2023

May 15, 2023
BUY
$3.58 - $6.3 $150,503 - $264,852
42,040 Added 12.84%
369,490 $1.6 Million
Q4 2022

Feb 14, 2023
BUY
$3.18 - $7.0 $1.04 Million - $2.29 Million
327,450 New
327,450 $2.29 Million
Q4 2020

Feb 16, 2021
SELL
$6.99 - $9.26 $324,902 - $430,414
-46,481 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$8.49 - $19.54 $394,623 - $908,238
46,481 New
46,481 $395,000
Q2 2019

Aug 14, 2019
SELL
$22.93 - $42.84 $1.37 Million - $2.55 Million
-59,629 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$32.69 - $47.91 $1.95 Million - $2.86 Million
59,629 New
59,629 $2.32 Million

Others Institutions Holding WVE

# of Institutions
164
Shares Held
117M
Call Options Held
148K
Put Options Held
109K
View Full List

About Wave Life Sciences Ltd.

WVE Quotes by TradingView
  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email